To determine if there is a subgroup of human ER + tumors that display a loss of SIRT3/MnSOD-Ac signature, we analyzed breast cancer patient tissue microarray (TMA) slides containing all four subtypes of breast malignancies. This evidence concerns the gene SOD2 and breast cancer.